News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,916 Results
Type
Article (14018)
Company Profile (304)
Press Release (248594)
Section
Business (79415)
Career Advice (152)
Deals (13208)
Drug Delivery (34)
Drug Development (50361)
Employer Resources (31)
FDA (5691)
Job Trends (5122)
News (144223)
Policy (10018)
Tag
Academia (901)
Alliances (21578)
Alzheimer's disease (779)
Antibody-drug conjugate (ADC) (65)
Approvals (5679)
Artificial intelligence (80)
Bankruptcy (99)
Best Places to Work (4543)
Biotechnology (249)
Breast cancer (121)
Cancer (1003)
Cardiovascular disease (83)
Career advice (132)
CAR-T (82)
Cell therapy (241)
Clinical research (40339)
Collaboration (375)
Compensation (152)
COVID-19 (1013)
C-suite (99)
Cystic fibrosis (72)
Data (1048)
Diabetes (94)
Diagnostics (1218)
Earnings (29056)
Events (47381)
Executive appointments (302)
FDA (6118)
Funding (361)
Gene editing (70)
Gene therapy (180)
GLP-1 (327)
Government (1065)
Healthcare (6559)
Infectious disease (1054)
Inflammatory bowel disease (100)
IPO (7218)
Job creations (859)
Job search strategy (127)
Layoffs (191)
Legal (1377)
Lung cancer (146)
Lymphoma (63)
Manufacturing (91)
Medical device (2563)
Medtech (2564)
Mergers & acquisitions (6172)
Metabolic disorders (285)
Neuroscience (1059)
NextGen: Class of 2025 (2013)
Non-profit (850)
Northern California (1202)
Obesity (155)
Opinion (93)
Parkinson's disease (82)
Patents (68)
People (25231)
Phase I (14235)
Phase II (18754)
Phase III (11869)
Pipeline (447)
Postmarket research (851)
Preclinical (5979)
Radiopharmaceuticals (207)
Rare diseases (222)
Real estate (1411)
Regulatory (8351)
Research institute (932)
Series A (71)
Southern California (1080)
Startups (1967)
United States (9520)
Vaccines (174)
Weight loss (91)
Date
Today (76)
Last 7 days (223)
Last 30 days (1160)
Last 365 days (20416)
2025 (1044)
2024 (20574)
2023 (22414)
2022 (26825)
2021 (27813)
2020 (23357)
2019 (16229)
2018 (11745)
2017 (13745)
2016 (11840)
2015 (14349)
2014 (10393)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7428)
Location
Africa (146)
Asia (17015)
Australia (2871)
California (2737)
Canada (870)
China (248)
Colorado (101)
Connecticut (116)
Europe (36598)
Florida (306)
Georgia (79)
Illinois (169)
Indiana (67)
Maryland (365)
Massachusetts (2174)
Minnesota (111)
New Jersey (675)
New York (751)
North Carolina (443)
Northern California (1202)
Ohio (88)
Pennsylvania (524)
South America (207)
Southern California (1080)
Texas (307)
Washington State (266)
262,916 Results for "viridian therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Viridian Therapeutics, Inc. today announced that senior management will participate in the following upcoming investor conferences in June.
May 31, 2024
·
2 min read
Press Releases
Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
January 8, 2025
·
15 min read
Genetown
Viridian Therapeutics to Participate in Upcoming May Investor Conferences
Viridian Therapeutics, Inc. today announced that senior management will participate in the following upcoming investor conferences in May.
May 10, 2024
·
1 min read
Press Releases
Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024
December 16, 2024
·
4 min read
Press Releases
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2024
December 5, 2024
·
2 min read
Press Releases
Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease
December 16, 2024
·
13 min read
Press Releases
Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data
November 13, 2024
·
13 min read
Business
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Viridian Therapeutics, Inc., a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, reported recent business highlights and financial results for the first quarter ending March 31, 2024.
May 8, 2024
·
11 min read
Business
Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
Viridian Therapeutics, Inc. today announced it will host a webcast and conference call on Wednesday, May 8 at 8:00 a.m. ET to discuss its first quarter 2024 financial results and recent business highlights.
April 29, 2024
·
1 min read
Genetown
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 06, 2024
Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 450,000 shares of the company’s common stock to two new employees on June 3, 2024.
June 6, 2024
·
2 min read
1 of 26,292
Next
